Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Enhancing osteoblast differentiation and bone repair: The priming effect of photobiomodulation on adipose stromal cells.

Bueno NP., Hertel FC., Fernandes E Oliveira HF., Arany P., Beloti MM., Marques MM.

Animal Study on Face & Skin, published in J Photochem Photobiol B (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Photochem Photobiol B (2024)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
39388731
DOI
10.1016/j.jphotobiol.2024.113040

Abstract (original English)

Cellular therapy using adipose tissue-derived mesenchymal stromal cells (at-MSCs) has garnered attention for the treatment of bone defects. Therefore, preconditioning strategies to enhance the osteogenic potential of at-MSCs could optimize cell therapy outcomes, and photobiomodulation (PBM) therapy has emerged as an effective, noninvasive, and low-cost alternative. This study explored the impacts of PBM on at-MSCs differentiation and the subsequent repair of bone defects treated with cell injection. Rat at-MSCs were cultured and irradiated (at-MSCs PBM ) following the PBM protocol (660 nm; 20 mW; 0.714 W/cm 2 ; 0.14 J; 5 J/cm 2 ). Cellular differentiation was assessed based on the expression of gene and protein markers. Reactive oxygen species (ROS) were detected using fluorescence. At-MSCs PBM were injected into 5-mm calvarial lesions, and bone formation was analyzed using micro-CT and histological evaluations. At-MSCs were used as control. Data were analyzed using the ANOVA or t-test. At-MSCs PBM exhibited high levels of gene and protein runt-related transcription factor-2 (Runx2) and alkaline phosphatase (Alp) expression. PBM increased ALP activity and significantly reduced ROS levels. In addition, PBM increased the expression of Wnt pathway-associated genes. In vivo, there was an increase in the morphometric parameters, including bone volume, percentage of bone volume, bone

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsCell DifferentiationRatsReactive Oxygen SpeciesMesenchymal Stem CellsOsteoblastsLow-Level Light TherapyOsteogenesisAdipose TissueBone Regeneration

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research